English

Announcement regarding principal shareholder's ownership of Lundbeck

Report this content 
On 31 July 2008, H. Lundbeck A/S was notified that LFI A/S (the
Lundbeck Foundation) after today's registered change of the H.
Lundbeck A/S' share capital holds 69.7621% of the shares in Lundbeck
corresponding to 137,351,918 shares.

Lundbeck contacts


Investors:                 Media:

Jacob Tolstrup             Mads Vindahl Kronborg
Director                   Media Relations
+45 36 43 30 79            +45 36 43 28 51

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


Release No 351 - 31 July 2008



About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of
pharmaceuticals for the treatment of psychiatric and neurological
disorders. In 2007, the company's revenue was DKK 11 billion
(approximately EUR 1.6 billion or USD 2.0 billion). The number of
employees is approx. 5,300 globally. For more information, please
visit www.lundbeck.com.

Subscribe